BENZENO SHARON Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
3
Insider Sells Sum
$513,475.42

Insider Activity of BENZENO SHARON

According to the SEC Form 4 filings, BENZENO SHARON, being in a position of

  1. Chief Commercial Ofc Imm Med at Adaptive Biotechnologies Corporation,
    оver the last 12 months, has bought 0 shares, and sold 847911 share for $14.69M,
    over all time since 2023-03-06, has bought 0 shares, and sold 933715 shares for $15.2M.

Biography of BENZENO SHARON

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$14,690,9796100

Comparison of Insiders on Amount of Buys and Sells

2026-06-29SaleAdaptive Biotechnologies Corporation
ADPT
Chief Commercial Ofc Imm Med
154,768
0.0955%
$21.14$3.27M+16.45%
2026-06-26SaleAdaptive Biotechnologies Corporation
ADPT
Chief Commercial Ofc Imm Med
11,034
0.0069%
$21.00$231,714+18.56%
2026-03-11SaleAdaptive Biotechnologies Corporation
ADPT
Chief Commercial Ofc Imm Med
63,103
0.038%
$13.17$831,067+51.02%
2025-12-04SaleAdaptive Biotechnologies Corporation
ADPT
Chief Commercial Ofc Imm Med
12,604
0.008%
$16.85$212,377-0.29%
2025-11-21SaleAdaptive Biotechnologies Corporation
ADPT
Chief Commercial Ofc Imm Med
308,477
0.1836%
$16.91$5.22M-5.86%
2025-11-20SaleAdaptive Biotechnologies Corporation
ADPT
Chief Commercial Ofc Imm Med
297,925
0.1978%
$16.54$4.93M+7.38%
2025-03-05SaleAdaptive Biotechnologies Corporation
ADPT
Chief Commercial Ofc Imm Med
44,665
0.0266%
$6.98$311,792+60.77%
2024-03-05SaleAdaptive Biotechnologies Corporation
ADPT
Chief Commercial Ofc Imm Med
29,390
0.0115%
$3.44$100,994+19.44%
2023-03-06SaleAdaptive Biotechnologies Corporation
ADPT
Chief Commercial Ofc Imm Med
11,749
0.0115%
$8.57$100,689-26.95%
Total: 9
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.